{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:37:08Z","timestamp":1761215828784,"version":"build-2065373602"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Deficiency in\n                      <jats:italic>ELF4<\/jats:italic>\n                      , X-linked (DEX) is a recently recognized monogenic autoinflammatory disorder and a novel type of congenital immunodeficiency. Due to the limited number of reported cases, understanding of DEX remains incomplete. In clinical settings, children with this condition are often misdiagnosed as having diseases such as Beh\u00e7et\u2019s disease or inflammatory bowel disease, due to overlapping clinical features.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Genomic DNA was isolated from peripheral blood samples for genetic analysis, and genomic DNA was extracted from the peripheral blood samples of the proband\u2019s mother for x chromosome inactivation (XCI) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on the clinical and genetic characteristics of a 3-year-old male patient with DEX in China. This study offers a detailed exploration of the child\u2019s specific clinical symptoms and treatment approach, in addition to a comprehensive review of the primary clinical manifestations and genotypic traits of individuals with DEX.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study aims to increase clinicians\u2019 understanding of DEX. In cases where young male patients present with recurrent fever, oral or mucosal ulcers, or repeated infections, DEX should be strongly considered. Early implementation of gastrointestinal endoscopy and genetic testing is recommended to enable a more precise and timely diagnosis, laying a solid foundation for informed treatment decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04039-x","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:21:03Z","timestamp":1761214863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel pathogenic variant in the deficiency in ELF4, X-linked (DEX): case report and literature review"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9806-2112","authenticated-orcid":false,"given":"Lin","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaomiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"4039_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ni1023","volume":"5","author":"A Fischer","year":"2004","unstructured":"Fischer A. Human primary immunodefciency diseases: a perspective. Nat Immunol. 2004;5:23\u201330.","journal-title":"Nat Immunol"},{"issue":"9","key":"4039_CR2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41590-021-00984-4","volume":"22","author":"PM Tyler","year":"2021","unstructured":"Tyler PM, Bucklin ML, Zhao M, et al. Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation. Nat Immunol. 2021;22(9):1118\u201326. https:\/\/doi.org\/10.1038\/s41590-021-00984-4.","journal-title":"Nat Immunol"},{"issue":"4","key":"4039_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s10875-022-01243-3","volume":"42","author":"G Sun","year":"2022","unstructured":"Sun G, Qiu L, Yu L, et al. Loss of function mutation in ELF4 causes autoinflammatory and immunodeficiency disease in human. J Clin Immunol. 2022;42(4):798\u2013810. https:\/\/doi.org\/10.1007\/s10875-022-01243-3.","journal-title":"J Clin Immunol"},{"issue":"7","key":"4039_CR4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye SG, Ai-herzl W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;42(7):1473\u2013507. https:\/\/doi.org\/10.1007\/s10875-022-01289-3.","journal-title":"J Clin Immunol"},{"issue":"5","key":"4039_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular Pathology[J]. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"issue":"5","key":"4039_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10875-023-01453-3","volume":"43","author":"G Sun","year":"2023","unstructured":"Sun G, Wu M, Lv Q, et al. A multicenter cohort study of immune dysregulation disorders caused by ELF4 variants in China[J]. J Clin Immunol. 2023;43(5):933\u20139. https:\/\/doi.org\/10.1007\/s10875-023-01453-3.","journal-title":"J Clin Immunol"},{"issue":"2","key":"4039_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10875-023-01610-8","volume":"44","author":"SJ Olyha","year":"2024","unstructured":"Olyha SJ, O\u2032Connor SK, Kribis M, et al. Deficiency in ELF4, X-linked: a Monogenic disease entity resembling beh\u00e7et\u2032s syndrome and inflammatory bowel disease[J]. J Clin Immunol. 2024;44(2):44. 10.1007\/ s10875-023-01610-8.","journal-title":"J Clin Immunol"},{"issue":"6","key":"4039_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10875-024-01732-7","volume":"44","author":"L Sun","year":"2024","unstructured":"Sun L, Han Y, Li B, et al. A novel frameshift variant of the ELF4 gene in a patient with autoinflammatory disease: clinical Features, transcriptomic profiling and functional Studies[J]. J Clin Immunol. 2024;44(6):127. https:\/\/doi.org\/10.1007\/s10875-024-01732-7.","journal-title":"J Clin Immunol"},{"issue":"12","key":"4039_CR9","first-page":"1164","volume":"62","author":"WANG Zhou Yu","year":"2019","unstructured":"Zhou Yu WANG, Libo ZHANG, Chunyan. Two cases of X-linked ELF4 gene defect and literature review [J]. Chin J Pediatr. 2019;62(12):1164\u20138.","journal-title":"Chin J Pediatr"},{"issue":"3","key":"4039_CR10","first-page":"756","volume":"55","author":"XIE Wang Nan","year":"2019","unstructured":"Wang Nan XIE, Yongmei WANG. 2 cases of behcet\u2019s disease like syndrome with ELF4 gene defect [J]. J Sichuan Univ (Med Edition). 2019;55(3):756\u201361.","journal-title":"J Sichuan Univ (Med Edition)"},{"issue":"3","key":"4039_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/jmcb\/mjw051","volume":"9","author":"MA SUICO","year":"2017","unstructured":"SUICO MA, SHUTO T. Roles and regulations of the ETS transcription factor ELF4\/MEF. J Mol Cell Biol. 2017;9(3):168\u201377. https:\/\/doi.org\/10.1093\/jmcb\/mjw051.","journal-title":"J Mol Cell Biol"},{"key":"4039_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.1730","volume":"10","author":"T Yamada","year":"2009","unstructured":"Yamada T, Park CS, Mamonkin M, Lacorazza HD. Transcription factor ELF4 controls the proliferation and homing of CD8\u2009+\u2009T cells via the Kr\u00fcppel-like factors KLF4 and KLF2. Nat Immunol. 2009;10:618\u201326.","journal-title":"Nat Immunol"},{"issue":"1","key":"4039_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4049\/jimmunol.1301372","volume":"192","author":"PH Lee","year":"2014","unstructured":"Lee PH, Puppi M, Schluns KS, et al. The transcription factor E74- like factor 4 suppresses differentiation of proliferating CD4\u2009+\u2009T cells to the Th17 lineage. J Immunol. 2014;192(1):178\u201388.","journal-title":"J Immunol"},{"key":"4039_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1074-7613(02)00422-3","volume":"17","author":"HD Lacorazza","year":"2002","unstructured":"Lacorazza HD, Miyazaki Y, di Cristofano A, Deblasio A, Hedvat C, Zhang J, et al. The ETS protein MEF plays a critical role in Perforin gene expression and the development of natural killer and NK-T cells. Immunity. 2002;17:437\u201349. https:\/\/doi.org\/10.1016\/S1074-7613(02)00422-3.","journal-title":"Immunity"},{"key":"4039_CR15","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1074\/jbc.M307524200","volume":"279","author":"CV Hedvat","year":"2004","unstructured":"Hedvat CV, Yao JJ, Sokolic RA, Nimer SD. Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells. J Biol Chem. 2004;279:6395\u2013400. https:\/\/doi.org\/10.1074\/jbc.M307524200.","journal-title":"J Biol Chem"},{"issue":"22","key":"4039_CR16","first-page":"6579","volume":"62","author":"Y Seki","year":"2002","unstructured":"Seki Y, Suico MA, Uto A, Hisatsune A, Shuto T, Isohama Y, et al. The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome. Cancer Res. 2002;62(22):6579\u201386.","journal-title":"Cancer Res"},{"key":"4039_CR17","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/ni.2756","volume":"14","author":"F You","year":"2013","unstructured":"You F, Wang P, Yang L, Yang G, Zhao YO, Qian F, et al. ELF4 is critical for induction of type i interferon and the host antiviral response. Nat Immunol. 2013;14:1237\u201346. https:\/\/doi.org\/10.1038\/ni.2756.","journal-title":"Nat Immunol"},{"key":"4039_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/cmi.2014.1","volume":"11","author":"A Szabo","year":"2014","unstructured":"Szabo A, Rajnavolgyi E. Finding a Fairy in the forest: ELF4, a novel and critical element of type I interferon responses. Cell Mol Immunol. 2014;11:218\u201320.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"4039_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s12519-024-00807-0","volume":"20","author":"HQ Du","year":"2024","unstructured":"Du HQ, Zhao XD. Current Understanding of ELF4 defciency: a novel inborn error of immunity. World J Pediatr. 2024;20(5):444\u201350. https:\/\/doi.org\/10.1007\/s12519-024-00807-0. Epub 2024 May 11.","journal-title":"World J Pediatr"},{"key":"4039_CR20","doi-asserted-by":"crossref","unstructured":"LITTMAN D R, RUDENSKY A Y. Th17 and regulatory T cells in mediating and restraining inflammation. Cell, 2010, 140(6): 845\u2013858. doi: 0.1016\/j.cell.2010.02.021.","DOI":"10.1016\/j.cell.2010.02.021"},{"key":"4039_CR21","doi-asserted-by":"publisher","unstructured":"van Rheenen PF, Aloi M, Assa A, et al. The medical management of paediatric crohn\u2032s disease: an ECCO-ESPGHAN guideline update[J]. J Crohns Colitis. 2020;jjaa161. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa161.","DOI":"10.1093\/ecco-jcc\/jjaa161"},{"key":"4039_CR22","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/ibd.20490","volume":"14","author":"T Sipponen","year":"2008","unstructured":"Sipponen T, Savilahti E, K\u00e4rkk\u00e4inen P, Kolho KL, Nuutinen H, Turunen U, et al. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for crohn\u2019s disease. Inflamm Bowel Dis. 2008;14:1392\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"4039_CR23","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1002\/ibd.22917","volume":"18","author":"G D\u2019Haens","year":"2012","unstructured":"D\u2019Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2218\u201324.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"4039_CR24","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.jaci.2023.03.006","volume":"151","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, He L, Yu Z, et al. Reversal of SLE and hemophagocytic lymphohistiocytosis caused by lysinuric protein intolerance through allogeneic hematopoietic stem cell transplantation[J]. J Allergy Clin Immunol. 2023;151(6):1673\u20134. https:\/\/doi.org\/10.1016\/j.jaci.2023.03.006.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04039-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:21:04Z","timestamp":1761214864000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-04039-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4039"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04039-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the responsible committee on human experimentation at Anhui Provincial Children\u2019s Hospital (APPROVAL NUMBER: EYLL-2024-042) on October 22, 2024, and with the Helsinki Declaration of 1964, as revised in 2013. Written consent for publication was obtained from the parents or legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no known competing financial interests or personal relationships that could have influenced the work presented in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"535"}}